Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GZ 389988

Drug Profile

GZ 389988

Alternative Names: GZ 389988A; GZ389988

Latest Information Update: 12 Feb 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genzyme Corporation
  • Developer Sanofi; Sanofi Genzyme
  • Class Antirheumatics; Small molecules
  • Mechanism of Action TrkA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Osteoarthritis

Most Recent Events

  • 31 Dec 2018 Discontinued - Phase-II for Osteoarthritis (In the elderly, In adults) in Germany (Intra-articular) before December 2018 (Sanofi pipeline, February 2019)
  • 31 Dec 2018 Discontinued - Preclinical for Osteoarthritis in USA (Intra-articular) before December 2018 (Sanofi pipeline, February 2019)
  • 31 Jul 2018 Sanofi announces its intention to submit regulatory application for Osteoarthritis in 2022
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top